Antiprogesterone and antiglucocorticoid actions of RU 486 on rabbit mammary gland explant cultures. Evidence for a persistent inhibitory action of residual progesterone upon the mammary tissue.
The antiprogesterone and antiglucocorticoid compound RU 486 added to pregnant rabbit mammary gland explant cultures had no effect alone but significantly stimulated casein production in the presence of ovine prolactin (PRL) in a dose dependent manner. This stimulation was inhibited by progesterone (Pg) and the Pg agonist R5020. When the explants were cultured for 5 days with two changes of medium, to eliminate all steroids, and hormones added afterwards, the effect of PRL was potentiated, Pg was no longer inhibitory and RU 486 had no effect, RU 486 also could inhibit the stimulatory action of glucocorticoids added to the cultures along with PRL. The compound was able to displace [3H]dexamethasone and [3H]R 5020 from mammary gland glucocorticoid and Pg receptors respectively and proved to have a high relative binding affinity (RBA) for both receptors when compared with typical ligands for each receptor. The RBAs of RU 486 and the steroids used in this study to mammary gland glucocorticoid and Pg receptors correlated well with the ability of RU 486 to block their biological activities. These results demonstrate that RU 486 has both antiglucocorticoid and antiprogesterone activities in pregnant rabbit mammary glands as well as the existence of a strong inhibitory residual action of Pg in the gland that persists during the first 48 h of culture and that can be eliminated by RU 486 or after several days of culture with no hormones.
Jahn
G A
GA
Laboratoire de Physiologie de la Lactation, INRA-CNRZ, Jouy-en-Josas, France.
Houdebine
L M
LM
Djiane
J
J
D000818:Animals; D002364:Caseins / Q000096:biosynthesis; D046508:Culture Techniques; D004247:DNA / Q000096:biosynthesis; D003907:Dexamethasone / Q000378:metabolism; D004963:Estrenes / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D005938:Glucocorticoids / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D008321:Mammary Glands, Animal / Q000187:drug effects / Q000378:metabolism*; D015735:Mifepristone; D011247:Pregnancy; D011374:Progesterone / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D011388:Prolactin / Q000494:pharmacology; D011397:Promegestone / Q000378:metabolism / Q000494:pharmacology; D011817:Rabbits; D011965:Receptors, Glucocorticoid / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism
D002364:Caseins; D004963:Estrenes; D005938:Glucocorticoids; D011965:Receptors, Glucocorticoid; D011980:Receptors, Progesterone; D015735:Mifepristone; D011374:Progesterone; D003907:Dexamethasone; D011388:Prolactin; D004247:DNA; D011397:Promegestone